CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW


TWO TECHNOLOGIES

ONE OBJECTIVE


To convert cancer and other degenerative diseases into non-lethal manageable conditions


Dr Graham Kelly, Executive Chairman

CLICK HERE TO READ THE LATEST CORPORATE OVERVIEW

CLICK HERE TO READ THE LATEST CORPORATE OVERVIEW

 

RESOURCES

All the Latest News >         STOP PRESS

Novogen Completes Private Placement to US Investors HERE

CEO on Private Placement  HERE

Novogen Raises A$4.1M In Private Placement HERE

Breakthrough in Treatment of Melanoma HERE

Instructions for Exercise of Novogen Options HERE

Article from -Ahead of the Curve- Mag. HERE

Update on Cantrixil Progress to Clinic HERE

Video Update on Cantrixil by Dr Kelly HERE

Novogen Receives $1.54M Tax Incentive HERE

 

 

 

 

 

 

 

CONTACT DETAILS

 

Novogen Enquiries
Dr Graham Kelly
CEO Novogen Group

Graham.Kelly@novogen.com
+(61 2) 9472 4100

 

Media Enquiries
Cristyn Humphreys
Operations Manager Novogen Group

Cristyn.Humphreys@Novogen.com
+ 61 2 9472 4111 / + 61 499 088 482